Captrust Financial Advisors Invests $628,000 in Inspire Medical Systems, Inc. (NYSE:INSP)

Captrust Financial Advisors acquired a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,975 shares of the company's stock, valued at approximately $628,000.

Several other hedge funds and other institutional investors also recently modified their holdings of INSP. Van ECK Associates Corp grew its stake in Inspire Medical Systems by 7.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,029 shares of the company's stock worth $138,000 after buying an additional 72 shares during the last quarter. Amalgamated Bank raised its position in shares of Inspire Medical Systems by 4.1% during the second quarter. Amalgamated Bank now owns 2,005 shares of the company's stock worth $268,000 after purchasing an additional 79 shares during the period. Signaturefd LLC lifted its stake in Inspire Medical Systems by 45.9% during the third quarter. Signaturefd LLC now owns 270 shares of the company's stock valued at $57,000 after buying an additional 85 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in Inspire Medical Systems by 0.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,193 shares of the company's stock valued at $2,836,000 after purchasing an additional 92 shares during the period. Finally, Gilliland Jeter Wealth Management LLC lifted its position in shares of Inspire Medical Systems by 0.8% in the second quarter. Gilliland Jeter Wealth Management LLC now owns 15,508 shares of the company's stock worth $2,075,000 after purchasing an additional 125 shares in the last quarter. Institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Trading Down 1.4 %

INSP stock traded down $2.77 during mid-day trading on Thursday, hitting $190.00. 327,936 shares of the company were exchanged, compared to its average volume of 586,828. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $257.40. The stock has a market capitalization of $5.69 billion, a PE ratio of 178.43 and a beta of 1.31. The business has a 50 day simple moving average of $195.14 and a 200-day simple moving average of $178.27.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm had revenue of $203.20 million during the quarter, compared to analysts' expectations of $197.59 million. During the same period in the prior year, the company earned ($0.29) earnings per share. The company's quarterly revenue was up 32.6% on a year-over-year basis. Equities research analysts expect that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Leerink Partners upped their target price on Inspire Medical Systems from $167.00 to $197.00 and gave the stock a "market perform" rating in a research report on Tuesday, September 10th. Robert W. Baird upped their price objective on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the stock an "outperform" rating in a report on Tuesday, November 5th. Truist Financial reissued a "buy" rating and set a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Royal Bank of Canada reiterated an "outperform" rating and set a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Stifel Nicolaus reissued a "hold" rating and set a $200.00 target price (up previously from $170.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $233.58.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.